Development and validation of a staging system for gastric adenocarcinoma after neoadjuvant chemotherapy and gastrectomy with D2 lymphadenectomy.
J X LinC YoonJ DesiderioB C YiP LiC H ZhengA ParisiC M HuangV E StrongJian-Xian LinPublished in: The British journal of surgery (2019)
The modified ypTNM staging system improves the accuracy of OS prediction for patients treated with neoadjuvant chemotherapy followed by gastrectomy with D2 lymphadenectomy.